SCHEMBL7453269

SCHEMBL7453269

CC(=O)N(Cc1cccc(Cl)c1)CN1CCCC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRM2 P08172 1/20 0.49
▸ CHRM4 P08173 1/20 0.49
▸ CHRM5 P08912 1/20 0.49
▸ CHRM1 P11229 1/20 0.49
▸ CHRM3 P20309 1/20 0.49
▸ SIGMAR1 Q99720 2/20 0.48
▸ SLC2A1 P11166 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.46
▸ LMNA P02545 1/20 0.46
▸ GAA P10253 1/20 0.46
▸ THRB P10828 1/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ KMT2A Q03164 2/20 0.45
▸ KDM4E B2RXH2 2/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ POLB P06746 1/20 0.45
▸ TSHR P16473 1/20 0.45
▸ RIPK1 Q13546 1/20 0.43
▸ SNCA P37840 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6434588 0.74 SLC2A1 (0.59) SIGMAR1SLC2A1ALDH1A1LMNAKMT2A
SCHEMBL9824208 0.72 RIPK1 (0.64) SLC2A1ALDH1A1GAAPOLBTSHR
SCHEMBL9841880 0.72 TSHR (0.52) SLC2A1ALDH1A1GAATSHRRIPK1
SCHEMBL3685681 0.71 CHRM2 (0.55) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL3169406 0.70 SIGMAR1 (0.79) SIGMAR1ALDH1A1GAAKDM4EHTT
SCHEMBL29447340 0.70 SIGMAR1 (0.79) SIGMAR1ALDH1A1GAAKDM4EHTT
SCHEMBL5732659 0.69 SIGMAR1 (0.77) SIGMAR1ALDH1A1GAAKDM4EHTT
SCHEMBL1890670 0.69 SIGMAR1 (0.77) SIGMAR1ALDH1A1GAAKDM4EHTT
SCHEMBL29447362 0.69 SIGMAR1 (0.77) SIGMAR1ALDH1A1GAAKDM4EHTT
Hydrochloric Acid SCHEMBL16825190 0.67 SIGMAR1 (0.74) SIGMAR1ALDH1A1GAAKDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1019529-A4 A METHOD OF TREATING CANCER MERCK & CO INC (US) 2002-09-11 — — EP disclosed
EP-1019529-A1 A METHOD OF TREATING CANCER Merck & Co., Inc. (US) 2000-07-19 — — EP disclosed
EP-1009854-A1 A METHOD OF TREATING CANCER Merck & Co., Inc. (US) 2000-06-21 — — EP disclosed
WO-2000016626-A1 A METHOD OF TREATING CANCER MERCK & CO., INC. (US) 2000-03-30 — — WO disclosed
WO-1999010525-A1 A METHOD OF TREATING CANCER MERCK & CO., INC. (US) 1999-03-04 — — WO disclosed
WO-1999010523-A1 A METHOD OF TREATING CANCER MERCK & CO., INC. (US) 1999-03-04 — — WO disclosed
Send feedback